Want to see GB:GNS full AI Analyst Report?
GNS Stock Chart & Stats
2664.00 p
-16.00 p(-1.07%)
At close: 4:00 PM EST
2664.00 p
-16.00 p(-1.07%)
Day’s Range― - ―
52-Week Range1,972.00 p - 3,228.80 p
Previous CloseN/A
Volume9.41K
Average Volume (3M)171.79K
Market Cap
£1.43B
Enterprise Value1.68B
Total Cash (Recent Filing)£43.40M
Total Debt (Recent Filing)£260.70M
Price to Earnings (P/E)29.8
Beta1.79
Next Earnings
Sep 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.25%
Share Statistics
EPS (TTM)0.72
Shares Outstanding66,539,440
10 Day Avg. Volume120,789
30 Day Avg. Volume171,792
Financial Highlights & Ratios
PEG Ratio0.50
Price to Book (P/B)2.83
Price to Sales (P/S)2.00
P/FCF Ratio27.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£3,100.00Price Target Upside16.37% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)1.03
Revenue Forecast (FY)£682.80M
Bulls Say, Bears Say
Bulls Say
FDA ApprovalGenus has secured FDA approval for its PRP gene edited pigs for use.
Financial PerformanceThe company reported better-than-expected performance in the first half of FY25, with significant growth in adjusted profit before tax.
Bears Say
Economic ConcernsThere is caution due to continued economic weakness in China and the possibility of tariff wars, which could impact the business negatively.
Regulatory UncertaintyUncertainty exists due to important regulatory and commercial hurdles for the PRP programme, affecting near-term confidence.
Genus plc News
GNS FAQ
What was Genus PLC’s price range in the past 12 months?
Genus PLC lowest share price was 1972.00 p and its highest was 3228.80 p in the past 12 months.
What is Genus PLC’s market cap?
Genus PLC’s market cap is £1.43B.
When is Genus PLC’s upcoming earnings report date?
Genus PLC’s upcoming earnings report date is Sep 10, 2026 which is in 71 days.
How were Genus PLC’s earnings last quarter?
Genus PLC released its earnings results on Feb 26, 2026. The company reported 0.6 p earnings per share for the quarter, beating the consensus estimate of 0.459 p by 0.141 p.
Is Genus PLC overvalued?
According to Wall Street analysts Genus PLC’s price is currently Undervalued.
Does Genus PLC pay dividends?
Genus PLC pays a Semiannually dividend of 11.2 p which represents an annual dividend yield of 1.25%. See more information on Genus PLC dividends here
What is Genus PLC’s EPS estimate?
Genus PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genus PLC have?
Genus PLC has 66,539,440 shares outstanding.
What happened to Genus PLC’s price movement after its last earnings report?
Genus PLC reported an EPS of 0.6 p in its last earnings report, beating expectations of 0.459 p. Following the earnings report the stock price went down -10.41%.
Which hedge fund is a major shareholder of Genus PLC?
Currently, no hedge funds are holding shares in GB:GNS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Genus plc Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
£3,100.00 (16.37% Upside)
£3,100.00 (16.37% Upside)
Blogger Sentiment
Bullish
GB:GNS Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth £94.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
32.07%
12-Months-Change
Fundamentals
Return on Equity
9.70%
Trailing 12-Months
Asset Growth
-6.55%
Trailing 12-Months
Company Description
Genus PLC
Genus plc is a global animal genetics company with operations spanning North America, Latin America, the UK, continental Europe, the Middle East, Russia, Africa, and Asia. The business is divided into three key segments: Genus PIC, Genus ABS, and Genus Research and Development. Under its PIC brand, the company provides breeding stock, including sows, boars, and semen, to develop pigs with specific characteristics optimized for pork production. Similarly, for cattle, its ABS, Genus, and Bovec brands offer bull semen and embryos designed to produce calves with advantageous traits for either milk or beef output. Farmers also benefit from a range of specialized technical services, such as semen sexing and reproductive solutions. Genus plc is also strategically collaborating with Beijing Capital Agribusiness Co. Ltd on the research, development, and regulatory approval of porcine reproductive and respiratory syndrome virus (PRRSV)-resistant pigs in China. The company was established in 1994 and is based in Basingstoke, United Kingdom.
GNS Stock 12 Month Forecast
Average Price Target
3,100.00 p
▲(16.37% Upside)
Technical Analysis
Bioventix
―
Oxford BioDynamics
―
Fusion Antibodies Plc
―
4basebio UK Societas
―
Oxford Nanopore Technologies PLC
―
Options Prices
Currently, No data available
---








